Skip to main content
. Author manuscript; available in PMC: 2020 Jul 31.
Published in final edited form as: Histopathology. 2018 May 7;73(2):207–214. doi: 10.1111/his.13505

Table 3.

Copy number variants detected by Ion AmpliSeq Cancer Panel* among 23 cases

Tumour type Ion AmpliSeq Cancer Panel copy number alterations
Gene Gain (%) Loss (%)
Adenocarcinoma (n = 18) R81 2 (11.1)
EGFR 2 (11.1) -
KRAS 1 (5.5) -
ATM 1 (5.5)
MET 1 (5.5) -
STK11 1 (5.5) -
Squamous cell carcinoma (n = 3) Rs1 - 1 (33.3)
P/K3CA 1 (33.3%) -
Adenosquamous carcinoma (n = 2) ATM - 1 (50.0%)
*

ion Torrent, Life Technologies, Thermo Fisher Scientific, Waltham, Massachusetts.